Open AccessOutcomes in Patients with SARS-CoV-2 and Clostridioides difficile Coinfection
Author(s) -
Kanika Sehgal,
Hind J. Fadel,
Aaron J. Tande,
Darrell S. Pardi,
Sahil Khanna
Publication year - 2021
Publication title -
infection and drug resistance
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.033
H-Index - 39
ISSN - 1178-6973
DOI - 10.2147/idr.s305349
Subject(s) - medicine , coinfection , metronidazole , retrospective cohort study , colectomy , intensive care unit , covid-19 , disease , infectious disease (medical specialty) , antibiotics , virology , virus , ulcerative colitis , microbiology and biotechnology , biology
Coronavirus infectious disease 2019 (COVID-19) is primarily a respiratory disease. However, it may manifest with gastrointestinal symptoms that may overlap with Clostridioides difficile infection (CDI). COVID-19 appears to have higher mortality in those with comorbidities. We aimed to assess the outcomes of coinfection in these patients.